17 17 McMahon MJ, Pickford IR. Biochemical prediction of gallstones early in an attack of acute pancreatitis. Lancet 1979; 314(8142):541–543.
18 18 Dholakia K, Pitchumoni CS, Agarwal N. How often are liver function tests normal in acute biliary pancreatitis? J Clin Gastroenterol 2004; 38:81–83.
19 19 Ammori BJ, Boreham B, Lewis P, et al. The biochemical detection of biliary etiology of acute pancreatitis on admission: a revisit in the modern era of biliary imaging. Pancreas 2003; 26:e32–e35.
20 20 Tenner S, Dubner H, Steinberg W. Predicting gallstone pancreatitis with laboratory parameters: a meta‐analysis. Am J Gastroenterol 1994; 89:1863–1866.
21 21 Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013; 108:1400–1415; 1416.
22 22 Goodman AJ, Neoptolemos JP, Carr‐Locke DL, et al. Detection of gall stones after acute pancreatitis. Gut 1985; 26:125–132.
23 23 Sugiyama M, Atomi Y. Acute biliary pancreatitis: the roles of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography. Surgery 1998; 124:14–21.
24 24 Moon JH, Cho YD, Cha SW, et al. The detection of bile duct stones in suspected biliary pancreatitis: comparison of MRCP, ERCP, and intraductal US. Am J Gastroenterol 2005; 100:1051–1057.
25 25 Bruno MJ. Endoscopic ultrasonography. Endoscopy 2006; 38:1098–1105.
26 26 Makary MA, Duncan MD, Harmon JW, et al. The role of magnetic resonance cholangiography in the management of patients with gallstone pancreatitis. Ann Surg 2005; 241:119–124.
27 27 Kimura Y, Takada T, Kawarada Y, et al. JPN Guidelines for the management of acute pancreatitis: treatment of gallstone‐induced acute pancreatitis. J Hepatobiliary Pancreat Surg 2006; 13:56–60.
28 28 Forsmark CE, Baillie J, AGA Institute Clinical Practice and Economics Committee, et al. AGA Institute technical review on acute pancreatitis. Gastroenterology 2007; 132:2022–2044.
29 29 Ros E, Navarro S, Bru C, et al. Occult microlithiasis in “idiopathic” acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology 1991; 101:1701–1709.
30 30 Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992; 326:589–593.
31 31 Sherman S, Jamidar P, Reber H. Idiopathic acute pancreatitis (IAP): endoscopic approach to diagnosis and therapy [abstract]. Am J Gastroenterol 1993;88: 1541A.
32 32 Kaw M, Verma R, Brodmerkel GJ. ERCP, biliary analysis, sphincter of Oddi manometry (SOM) in idiopathic pancreatitis (IP) and response to endoscopic sphincterotomy (ES) [abstract]. Am J Gastroenterol 1996;91: 1935A.
33 33 Garg PK, Tandon RK, Madan K. Is biliary microlithiasis a significant cause of idiopathic recurrent acute pancreatitis? A long‐term follow‐up study. Clin Gastroenterol Hepatol 2007; 5:75–79.
34 34 Wilcox CM, Seay T, Kim H, Varadarajulu S. Prospective Endoscopic ultrasound‐based approach to the evaluation of idiopathic pancreatitis: causes, response to therapy, and long‐term outcome. Am J Gastroenterol 2016; 111(9):1339–1348.
35 35 Dahan P, Andant C, Lévy P, et al. Prospective evaluation of endoscopic ultrasonography and microscopic examination of duodenal bile in the diagnosis of cholecystolithiasis in 45 patients with normal conventional ultrasonography. Gut 1996; 38:277–281.
36 36 Grau F, Almela P, Aparisi L, et al. Usefulness of alanine and aspartate aminotransferases in the diagnosis of microlithiasis in idiopathic acute pancreatitis. Int J Pancreatol 1999; 25:107–111.
37 37 Mustafa A, Begaj I, Deakin M, et al. Long‐term effectiveness of cholecystectomy and endoscopic sphincterotomy in the management of gallstone pancreatitis. Surg Endosc 2014; 28:127–133.
38 38 Cawley T. A singular case of diabetes, consisting entirely in the quality of the urine; with an inquiry into the different theories of that disease. Lond Med J 1788; 9:286–308.
39 39 Kume K, Masamune A, Ariga H, et al. Alcohol consumption and the risk for developing pancreatitis: a case‐control study in Japan. Pancreas 2015; 44:53–58.
40 40 Rebours V, Vullierme M‐P, Hentic O, et al. Smoking and the course of recurrent acute and chronic alcoholic pancreatitis: a dose‐dependent relationship. Pancreas 2012; 41:1219–1224.
41 41 Juliusson SJ, Nielsen JK, Runarsdottir V, et al. Lifetime alcohol intake and pattern of alcohol consumption in patients with alcohol‐induced pancreatitis in comparison with patients with alcohol use disorder. Scand J Gastroenterol 2018; 53:748–754.
42 42 Whitcomb DC. Genetic polymorphisms in alcoholic pancreatitis. Dig Dis 2005; 23:247–254.
43 43 Badalov N, Baradarian R, Iswara K, et al. Drug‐induced acute pancreatitis: an evidence‐based review. Clin Gastroenterol Hepatol 2007; 5:648–661; quiz 644.
44 44 Chang Y‐T, Chang M‐C, Su T‐C, et al. Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clin Chem 2008; 54:131–138.
45 45 Fortson MR, Freedman SN, Webster PD. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995; 90:2134–2139.
46 46 Jin M, Peng JM, Zhu HD, et al. Continuous intravenous infusion of insulin and heparin vs plasma exchange in hypertriglyceridemia‐induced acute pancreatitis. J Dig Dis 2018; 19:766–772.
47 47 Gelrud A, Digenio A, Alexander VJ, et al. Treatment with volanesorsen (VLN) reduced triglycerides and pancreatitis in patients with FCS and sHTG vs placebo: results of the APPROACH and COMPASS studies. Atheroscler Suppl 2018; 32:157.
48 48 Sadr‐Azodi O, Andrén‐Sandberg Å, Orsini N, et al. Cigarette smoking, smoking cessation and acute pancreatitis: a prospective population‐based study. Gut 2012; 61:262–267.
49 49 Yuhara H, Ogawa M, Kawaguchi Y, et al. Smoking and risk for acute pancreatitis: a systematic review and meta‐analysis. Pancreas 2014; 43:1201–1207.
50 50 Noel P, Patel K, Durgampudi C, et al. Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections. Gut 2016; 65:100–111.
51 51 Girman CJ, Kou TD, Cai B, et al. Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. Diabetes Obes Metab 2010; 12:766–771.
52 52 Urushihara H, Taketsuna M, Liu Y, et al. Increased risk of acute pancreatitis in patients with type 2 diabetes: an observational study using a Japanese hospital database. PLoS One 2012; 7:e53224.
53 53 Lai S‐W, Muo C‐H, Liao K‐F, et al. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti‐diabetic drugs: a population‐based cohort study in Taiwan. Am J Gastroenterol 2011; 106:1697–1704.
54 54 Rösch T. Staging of pancreatic cancer. Analysis of literature results. Gastrointest Endosc Clin North Am 1995; 5:735–739.
55 55 Wang AY, Yachimski PS. Endoscopic management of pancreatobiliary neoplasms. Gastroenterology 2018; 154:1947–1963.
56 56 Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37:383–393.
57 57 Masci E, Mariani A, Curioni S, et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta‐analysis. Endoscopy 2003; 35:830–834.
58 58 Kochar B, Akshintala VS, Afghani E, et al. Incidence, severity, and mortality of post‐ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc 2015; 81:143–149.e9.
59 59 Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post‐ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol